Modulation of mitochondrial dysfunction-related oxidative stress in fibroblasts of patients with Leigh syndrome by inhibition of prooxidative p66Shc pathway

Mitochondrion - Tập 37 - Trang 62-79 - 2017
Aleksandra Wojtala1, Agnieszka Karkucinska-Wieckowska2, Vilma A. Sardao3, Joanna Szczepanowska1, Pawel Kowalski4, Maciej Pronicki2, Jerzy Duszynski1, Mariusz R. Wieckowski1
1Department of Biochemistry, Nencki Institute of Experimental Biology, Warsaw, Poland
2Department of Pathology, The Children’s Memorial Health Institute, Warsaw, Poland
3CNC – Center for Neuroscience and Cell Biology, University of Coimbra, UC-Biotech Building, Biocant Park, Cantanhede, Portugal
4Department of Medical Genetics, The Children’s Memorial Health Institute, Warsaw, Poland

Tài liệu tham khảo

Baertling, 2014, A guide to diagnosis and treatment of Leigh syndrome, J. Neurol. Neurosurg. Psychiatry, 85, 257, 10.1136/jnnp-2012-304426 Batandier, 2004, Opening of the mitochondrial permeability transition pore induces reactive oxygen species production at the level of the respiratory chain complex I, J. Biol. Chem., 279, 17197, 10.1074/jbc.M310329200 Be Tu, 2014, Anti-obesity effects of hispidin and alpinia zerumbet bioactives in 3t3-l1 adipocytes, Molecules, 19, 16656, 10.3390/molecules191016656 Be Tu, 2015, Hispidin and related herbal compounds from Alpinia zerumbet inhibit both PAK1-dependent melanogenesis in melanocytes and reactive oxygen species (ROS) production in adipocytes, Drug Discov. Ther., 9, 197, 10.5582/ddt.2015.01038 Chen, 2012, Hispidin produced from Phellinus linteus protects against peroxynitrite-mediated DNA damage and hydroxyl radical generation, Chem. Biol. Interact., 199, 137, 10.1016/j.cbi.2012.07.001 Figueira, 2013, Mitochondria as a source of reactive oxygen and nitrogen species: from molecular mechanisms to human health, Antioxid. Redox Signal., 18, 2029, 10.1089/ars.2012.4729 Finsterer, 2008, Leigh and Leigh-like syndrome in children and adults, Pediatr. Neurol., 39, 223, 10.1016/j.pediatrneurol.2008.07.013 Fiskum, 2003, Mitochondrial mechanisms of neural cell death and neuroprotective interventions in Parkinson's disease, Ann. N. Y. Acad. Sci., 991, 111, 10.1111/j.1749-6632.2003.tb07469.x Genova, 2004, The mitochondrial production of reactive oxygen species in relation to aging and pathology, Ann. N. Y. Acad. Sci., 1011, 86, 10.1196/annals.1293.010 Gonindard, 1997, Synthetic hispidin, a PKC inhibitor, is more cytotoxic toward cancer cells than normal cells in vitro, Cell Biol. Toxicol., 13, 141, 10.1023/A:1007321227010 Haas, 2007, The evidence basis for coenzyme Q therapy in oxidative phosphorylation disease, Mitochondrion, 7, S136, 10.1016/j.mito.2007.03.008 Hu, 2007, PKC delta phosphorylates p52ShcA at Ser29 to regulate ERK activation in response to H2O2, Cell. Signal., 19, 410, 10.1016/j.cellsig.2006.07.017 Jang, 2010, Hispidin produced from Phellinus linteus protects pancreatic B-cells from damage by hydrogen peroxide, Arch. Pharm. Res., 33, 853, 10.1007/s12272-010-0607-5 Karkucinska-Wieckowska, 2015, Histoenzymatic methods for visualization of the activity of individual mitochondrial respiratory chain complexes in the muscle biopsies from patients with mitochondrial defects, Methods Mol. Biol., 1241, 85, 10.1007/978-1-4939-1875-1_8 Kawakami, 2002, Protein kinase C beta (PKC beta): normal functions and diseases, J. Biochem., 132, 677, 10.1093/oxfordjournals.jbchem.a003273 Kim, 2014, The protective effect of hispidin against hydrogen peroxide-induced apoptosis in H9c2 cardiomyoblast cells through Akt/GSK-3 and ERK1/2 signaling pathway, Exp. Cell Res., 327, 264, 10.1016/j.yexcr.2014.07.037 Koopman, 2007, Human NADH:ubiquinone oxidoreductase deficiency: radical changes in mitochondrial morphology, Am. J. Physiol. Cell Physiol., 293, C22, 10.1152/ajpcell.00194.2006 Kushnareva, 2002, Complex I-mediated reactive oxygen species generation: modulation by cytochrome c and NAD(P)+ oxidation-reduction state, Biochem. J., 368, 545, 10.1042/bj20021121 Lake, 2015, Leigh syndrome: neuropathology and pathogenesis, J. Neuropathol. Exp. Neurol., 74, 482, 10.1097/NEN.0000000000000195 Le, 2001, c-Jun N-terminal kinase specifically phosphorylates p66ShcA at serine 36 in response to ultraviolet irradiation, J. Biol. Chem., 276, 48332, 10.1074/jbc.M106612200 Lebiedzinska, 2010, Oxidative stress-dependent p66Shc phosphorylation in skin fibroblasts of children with mitochondrial disorders, Biochim. Biophys. Acta Bioenerg., 1797, 952, 10.1016/j.bbabio.2010.03.005 Lebiedzinska, 2013, Disrupted ATP synthase activity and mitochondrial hyperpolarisation-dependent oxidative stress is associated with p66Shc phosphorylation in fibroblasts of NARP patients, Int. J. Biochem. Cell Biol., 45, 141, 10.1016/j.biocel.2012.07.020 Lee, 2007, Highly oxygenated and unsaturated metabolites providing a diversity of hispidin class antioxidants in the medicinal mushrooms Inonotus and Phellinus, Bioorganic Med. Chem., 15, 3309, 10.1016/j.bmc.2007.03.039 Lee, 2000, Increase of mitochondria and mitochondrial DNA in response to oxidative stress in human cells, Biochem. J., 348, 425, 10.1042/bj3480425 Lee, 2002, Increase in mitochondrial mass in human fibroblasts under oxidative stress and during replicative cell senescence, J. Biomed. Sci., 9, 517, 10.1007/BF02254978 Lee, 2011, Hispidin isolated from Phellinus linteus protects against hydrogen peroxide-induced oxidative stress in pancreatic MIN6N beta-cells, J Med Food, 14, 1431, 10.1089/jmf.2010.1493 Leigh, 1951, Subacute necrotizing encephalomyelopathy in an infant, J. Neurol. Neurosurg. Psychiatry, 14, 216, 10.1136/jnnp.14.3.216 Linnane, 2007, Coenzyme Q(10)—its role as a prooxidant in the formation of superoxide anion/hydrogen peroxide and the regulation of the metabolome, Mitochondrion, 7, S51, 10.1016/j.mito.2007.03.005 McKenzie, 2007, Mitochondrial ND5 gene variation associated with encephalomyopathy and mitochondrial ATP consumption, J. Biol. Chem., 282, 36845, 10.1074/jbc.M704158200 Migliaccio, 1999, The p66shc adaptor protein controls oxidative stress response and life span in mammals, Nature, 402, 309, 10.1038/46311 Nambudiri, 1973, Effect of light on enzymes of phenylpropanoid metabolism and hispidin biosynthesis in Polyporus hispidus, Biochem. J., 134, 891, 10.1042/bj1340891 Napoli, 2003, Deletion of the p66Shc longevity gene reduces systemic and tissue oxidative stress, vascular cell apoptosis, and early atherogenesis in mice fed a high-fat diet, Proc. Natl. Acad. Sci. U. S. A., 100, 2112, 10.1073/pnas.0336359100 Nesbitt, 2012, The clinical spectrum of the m.10191T/C mutation in complex I-deficient Leigh syndrome, Dev. Med. Child Neurol., 54, 500, 10.1111/j.1469-8749.2012.04224.x Paradies, 2002, Reactive oxygen species affect mitochondrial electron transport complex I activity through oxidative cardiolipin damage, Gene, 286, 135, 10.1016/S0378-1119(01)00814-9 Parikh, 2009, A modern approach to the treatment of mitochondrial disease, Curr. Treat. Options Neurol., 11, 414, 10.1007/s11940-009-0046-0 Pelicci, 1992, A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction, Cell, 70, 93, 10.1016/0092-8674(92)90536-L Pellegrini, 2005, p66SHC: the apoptotic side of Shc proteins, Apoptosis, 10, 13, 10.1007/s10495-005-6057-8 Piekutowska-Abramczuk, 2008, The molecular background of Leigh syndrome, Neurol. Neurochir. Pol., 42, 238 Pinton, 2008, p66Shc, oxidative stress and aging: importing a lifespan determinant into mitochondria, Cell Cycle, 7, 304, 10.4161/cc.7.3.5360 Pinton, 2007, Protein kinase C beta and prolyl isomerase 1 regulate mitochondrial effects of the life-span determinant p66Shc, Science, 315, 659, 10.1126/science.1135380 Purdom, 2003, p66Shc: at the crossroad of oxidative stress and the genetics of aging, Trends Mol. Med., 9, 206, 10.1016/S1471-4914(03)00048-0 Rahman, 2015, Emerging aspects of treatment in mitochondrial disorders, Journal of Inherited Metabolic Disease, 38, 641, 10.1007/s10545-015-9855-3 Rigoulet, 2011, Mitochondrial ROS generation and its regulation: mechanisms involved in H2O2 signaling, Antioxid. Redox Signal., 14, 459, 10.1089/ars.2010.3363 Robinson, 1992, Nonviability of cells with oxidative defects in galactose medium: a screening test for affected patient fibroblasts, Biochem. Med. Metab. Biol., 48, 122, 10.1016/0885-4505(92)90056-5 Ruhoy, 2014, The genetics of Leigh syndrome and its implications for clinical practice and risk management, Appl. Clin. Genet., 7, 221 Suski, 2011, p66Shc aging protein in control of fibroblasts cell fate, Int. J. Mol. Sci., 12, 5373, 10.3390/ijms12085373 Ugalde, 2004, Differences in assembly or stability of complex I and other mitochondrial OXPHOS complexes in inherited complex I deficiency, Hum. Mol. Genet., 13, 659, 10.1093/hmg/ddh071 Valsecchi, 2012, Metabolic consequences of NDUFS4 gene deletion in immortalized mouse embryonic fibroblasts, Biochim. Biophys. Acta Bioenerg., 1817, 1925, 10.1016/j.bbabio.2012.03.006 Verkaart, 2007, Mitochondrial and cytosolic thiol redox state are not detectably altered in isolated human NADH:ubiquinone oxidoreductase deficiency, Biochim. Biophys. Acta - Mol. Basis Dis., 1772, 1041, 10.1016/j.bbadis.2007.05.004 Vichai, 2006, Sulforhodamine B colorimetric assay for cytotoxicity screening, Nat. Protoc., 1, 1112, 10.1038/nprot.2006.179 Wallace, 1999, Mitochondrial diseases in man and mouse, Science, 283, 1482, 10.1126/science.283.5407.1482 Yang, 2002, Distinct mechanisms of taxol-induced serine phosphorylation of the 66-kDa Shc isoform in A549 and RAW 264.7 cells, Biochim. Biophys. Acta, 12, 76, 10.1016/S0167-4889(02)00200-8